Table 1

The 10 Medicare Part D Drugs Selected for Price Negotiation for 2026 Include Drugs Used to Treat Cancer, Diabetes, Blood Clots, Heart Failure, Psoriasis, and Rheumatoid Arthritis

NOTE: *Total gross spending includes Medicare, plan, and beneficiary payments, not excluding any manufacturers’ rebates or other price concessions as CMS is prohibited from publicly disclosing such information. SOURCE: Centers for Medicare & Medicaid Services, Medicare Drug Price Negotiation Program: Selected Drugs for Initial Price Applicability Year 2026, August 29, 2023.
KFF.org (grey border)